Fig. 2From: Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysisProgression-free and overall survival according to treatment. a Progression-free survival. b Overall survival. HR = hazard ratioBack to article page